Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?

Lenders, Malte, Schmitz, Boris, Brand, Stefan-Martin, Brand, Eva
2018

ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA

Schelleckes, Katrin, Schmitz, Boris, Lenders, Malte, Mewes, Mirja, Brand, Stefan-Martin, Brand, Eva
2018

Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype

Schelleckes, Michael, Lenders, Malte, Guske, Katrin, Schmitz, Boris, Tanislav, Christian, Ständer, Sonja, Metze, Dieter, Katona, István, Weis, Joachim, Brand, Stefan-Martin, Duning, Thomas, Brand, Eva
2014

Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)

Reinecke, Holger, Breithardt, Günter, Engelbertz, Christiane Maria, Schmieder, Roland E., Fobker, Manfred, Pinnschmidt, Hans O., Schmitz, Boris, Bruland, Philipp, Wegscheider, Karl, Pavenstädt, Hermann-Joseph, Brand, Eva
2016

Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease

Schmitz, Boris, Kleber, Marcus E., Lenders, Malte, Delgado Gonzales de Kleber, Graciela, Engelbertz, Christiane Maria, Huang, Jie, Pavenstädt, Hermann-Joseph, Breithardt, Günter, Brand, Stefan-Martin, März, Winfried, Brand, Eva
2019

Die Regulation der Alpha-Galaktosidase A

ein komplementärer Ansatz aus funktionellen Analysen und klinischer Charakterisierung

Schelleckes, Michael
2014

Gewebespezifische und epigenetische Regulation der KIBRA-Expression in humanen Nieren- und Nervenzellen

Guske, Katrin
2014

Analysis of sAC expression and function as a co-factor of CREB

Herrmann, Mareike
2012